Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Modeling common Alzheimer’s disease with high and low polygenic risk in human iPSC: A large-scale research resource

Maguire, Emily, Winston, Jincy, Ellwood, Sarah, O'Donoghue, Rachel, Shaw, Bethany, Castillo Morales, Atahualpa, Keat, Samuel, Evans, Alexandra, Marshall, Rachel, Luckcuck, Lauren, Brown, Laura, Salis, Elisa, Leonenko, Ganna ORCID: https://orcid.org/0000-0001-8025-661X, Denning, Nicola, Allen, Nicholas ORCID: https://orcid.org/0000-0003-4009-186X, Escott-Price, Valentina ORCID: https://orcid.org/0000-0003-1784-5483, Webber, Caleb ORCID: https://orcid.org/0000-0001-8063-7674, Taylor, Philip R. ORCID: https://orcid.org/0000-0003-0163-1421, Sims, Rebecca ORCID: https://orcid.org/0000-0002-3885-1199, Cowley, Sally A., Williams, Julie ORCID: https://orcid.org/0000-0002-4069-0259, Carpanini, Sarah M., Hall-Roberts, Hazel and EADB Consortium 2025. Modeling common Alzheimer’s disease with high and low polygenic risk in human iPSC: A large-scale research resource. Stem Cell Reports 20 (8) , 102570. 10.1016/j.stemcr.2025.102570

[thumbnail of PIIS2213671125001742.pdf]
Preview
PDF - Published Version
Available under License Creative Commons Attribution.

Download (5MB) | Preview

Abstract

Common forms of Alzheimer’s disease (AD) are complex and polygenic. We have created a research resource that seeks to capture the extremes of polygenic risk in a collection of human induced pluripotent stem cell (iPSC) lines from over 100 donors: the IPMAR Resource (iPSC Platform to Model Alzheimer's Disease Risk). Donors were selected from a large UK cohort of 6,000+ research-diagnosed early or late-onset AD cases and elderly cognitively healthy controls, many of whom have lived through the age of risk for disease development (>85 years). We include iPSC with extremes of global AD polygenic risk (high-risk late-onset AD: 34; high-risk early-onset AD: 29; low-risk control: 27) as well as those reflecting complement pathway-specific genetic risk (high-risk AD: 9; low-risk controls: 10). All iPSC have associated clinical, longitudinal, and genetic datasets and will be available through collaboration or from cell (EBiSC) and data (DPUK) repositories.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Professional Services > Advanced Research Computing @ Cardiff (ARCCA)
Schools > Biosciences
Schools > Medicine
Publisher: Cell Press
ISSN: 2213-6711
Date of First Compliant Deposit: 19 June 2025
Date of Acceptance: 5 June 2025
Last Modified: 23 Sep 2025 12:47
URI: https://orca.cardiff.ac.uk/id/eprint/178829

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics